These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29490686)

  • 41. A Single-Molecule View of Genome Editing Proteins: Biophysical Mechanisms for TALEs and CRISPR/Cas9.
    Cuculis L; Schroeder CM
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():577-597. PubMed ID: 28489428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.
    Gori JL; Hsu PD; Maeder ML; Shen S; Welstead GG; Bumcrot D
    Hum Gene Ther; 2015 Jul; 26(7):443-51. PubMed ID: 26068008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The CRISPR tool kit for genome editing and beyond.
    Adli M
    Nat Commun; 2018 May; 9(1):1911. PubMed ID: 29765029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Genome editing technology and its application in forage legumes].
    Liu H; Meng Y; Niu L; Lin H
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1733-1743. PubMed ID: 29082721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box.
    Karlgren M; Simoff I; Keiser M; Oswald S; Artursson P
    Drug Metab Dispos; 2018 Nov; 46(11):1776-1786. PubMed ID: 30126863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful correction of hemophilia by CRISPR/Cas9 genome editing in vivo: delivery vector and immune responses are the key to success.
    Nguyen TH; Anegon I
    EMBO Mol Med; 2016 May; 8(5):439-41. PubMed ID: 27138565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach.
    Tremblay JP; Iyombe-Engembe JP; Duchêne B; Ouellet DL
    Mol Ther; 2016 Nov; 24(11):1888-1889. PubMed ID: 27916992
    [No Abstract]   [Full Text] [Related]  

  • 52. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system.
    Yin L; Maddison LA; Chen W
    Methods Cell Biol; 2016; 135():3-17. PubMed ID: 27443918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of CRISPR/Cas9 mediated virus resistance in agriculturally important crops.
    Khatodia S; Bhatotia K; Tuteja N
    Bioengineered; 2017 May; 8(3):274-279. PubMed ID: 28581909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRISPR-Cpf1: A New Tool for Plant Genome Editing.
    Zaidi SS; Mahfouz MM; Mansoor S
    Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CRISPR-Cas9 therapies in experimental mouse models of cancer.
    Estêvão D; Rios Costa N; da Costa RG; Medeiros R
    Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiplex gene editing in rice with simplified CRISPR-Cpf1 and CRISPR-Cas9 systems.
    Wang M; Mao Y; Lu Y; Wang Z; Tao X; Zhu JK
    J Integr Plant Biol; 2018 Aug; 60(8):626-631. PubMed ID: 29762900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRISPR-mediated genome editing in non-conventional yeasts for biotechnological applications.
    Cai P; Gao J; Zhou Y
    Microb Cell Fact; 2019 Apr; 18(1):63. PubMed ID: 30940138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
    Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
    J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.